Bpifrance

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Edaphos is an international holding company providing eco-friendly soil remediation solutions to transform waste and barren soil into fertile soil.

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and their families, not just provide an incremental improvement or benefit over the standard-of-care. It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.

Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and their families, not just provide an incremental improvement or benefit over the standard-of-care. It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is headquartered in Basel, Switzerland, with research labs in Nice, France.

NeoXam is a financial software company that serves asset management and capital market firms by providing cost-efficient and reliable solutions. With over 150 clients across 25 countries, NeoXam processes more than $14 trillion in assets daily and supports over 10,000 users. The company specializes in automating complex processes through a hybrid delivery model, enabling financial institutions to access critical information consistently and optimize their operations. By leveraging a talented workforce of over 450 employees and maintaining offices in key financial hubs including Paris, New York, and Hong Kong, NeoXam helps both buy-side and sell-side entities navigate the evolving financial landscape, enhancing their ability to grow and serve their clients effectively.

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is headquartered in Basel, Switzerland, with research labs in Nice, France.

Webmecanik SAS is a marketing automation software provider based in Annecy, France. Originally founded as Eureos in 2013, the company rebranded in 2014 to focus on delivering innovative solutions powered by Mautic. Webmecanik specializes in offering an agency dashboard, myWebmecanik, which simplifies the deployment of new instances and management of client accounts for marketing agencies. With a growing presence that includes offices in Paris, Berlin, and Geneva, Webmecanik ensures that all client data and automation instances are securely hosted within Europe, allowing clients to choose hosting options in France, Switzerland, or Germany.

Recommerce Group specializes in the trade-in and remarketing of second-hand mobile phones, offering a comprehensive range of solutions for the refurbishment and resale of smartphones. The company employs advanced proprietary technologies to give new life to used devices, facilitating both buyback and resale processes. Its services encompass multi-channel trade-in solutions, including reverse logistics, data erasure, and customer support, as well as graphic design and web development for marketing initiatives. Recommerce Group also provides rental options for smartphones and tablets on flexible terms. Operating internationally, the company collaborates with prominent retailers and mobile network operators in France, Switzerland, and Spain, while maintaining a network of physical and online distribution channels. Founded in 2009 and headquartered in Paris, France, Recommerce Group also has additional offices in Grenoble, Warsaw, Madrid, and Fribourg, positioning itself as a leader in the European recommerce market.